(continued)
- Leqvio: New Injectable Option for Lowering Bad Cholesterol Without Statins
- Vizz: New Daily Eye Drop to Improve Age-Related Blurry Near Vision
- Alhemo: A New Daily Injection to Help Prevent Bleeding in Hemophilia A and B
- Empaveli: A New Treatment Option for Rare Immune-Related Kidney Diseases
- New Oral Treatment for Adults and Children With Phenylketonuria: Sephience
- New Oral Option for Children With Low Platelet Counts: Doptelet
- FDA OKs New Steroid-Free Skin Cream for Hand Eczema
- FDA OKs Moderna’s COVID Shot for Kids, With Limits
- FDA Approves First Oral Treatment for Rare Swelling Disorder
- FDA OKs First-of-Its-Kind Lung Cancer Pill
- FDA Greenlights New Treatment for Advanced Blood Cancer
- FDA Approves First Twice-Yearly Shot to Prevent HIV
- FDA OKs New Monthly Treatment for Rare Swelling Disorder
- More Adults Can Now Get Moderna's RSV Shot
- FDA OKs New Next-Gen Pill for Rare Lung Cancer
- FDA Approves New 3-in-1 Combo Pill for High Blood Pressure
- FDA OKs New Shot to Protect Babies Against RSV
- FDA Approves Moderna’s New COVID Vaccine With Restricted Use
- FDA Approves New Treatment for Dry Eye Disease
- FDA OKs First Meningococcal Vaccine for Infants
- FDA OKs Nucala for Hard-to-Treat COPD
- FDA Approves Novavax COVID Vaccine With Restricted Use
- FDA OKs New Treatment for Hard-to-Treat Lung Cancer
- FDA Approves New Oral Drug Combo for Rare Ovarian Cancer
- FDA Approves New Long-Term Treatment for Myasthenia Gravis
- FDA Approves New Gene Therapy for Rare Genetic Skin Disorder
- FDA OKs New Drug for Rare Head and Neck Cancer
- FDA Approves Dupixent for Chronic Skin Condition
- FDA Approves New Treatment for Serious Kidney Disorder
- New Hemophilia Treatment Wins FDA Approval